Amgen Inc. (AMGN) Financial Statements (2026 and earlier)

Company Profile

Business Address ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,97310,9449,3058,03710,6478,911
Cash and cash equivalent11,97310,9447,6297,9896,2666,037
Short-term investments   1,676484,3812,874
Receivables6,7827,2685,5634,8954,5254,057
Inventory, net of allowances, customer advances and progress billings6,9989,5184,9304,0863,8933,584
Inventory6,9989,5184,9304,0863,8933,584
Other current assets3,2772,6022,3882,3672,0791,888
Total current assets:29,03030,33222,18619,38521,14418,440
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization6,5435,9415,4275,1844,8894,928
Intangible asset, including goodwill, after accumulated amortization46,33651,27031,60930,07231,27634,116
Goodwill18,63718,62915,52914,89014,68914,703
Intangible asset, excluding goodwill, after accumulated amortization27,69932,64116,08015,18216,58719,413
Other noncurrent assets9,9309,6115,8996,5245,6392,223
Total noncurrent assets:62,80966,82242,93541,78041,80441,267
TOTAL ASSETS:91,83997,15465,12161,16562,94859,707
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities19,54916,94914,09612,09711,5629,882
Accounts payable1,9081,5901,5721,3661,4211,371
Accrued liabilities17,64115,35912,52410,73110,1418,511
Debt3,5501,4431,59187912,953
Total current liabilities:23,09918,39215,68712,18411,65312,835
Noncurrent Liabilities
Long-term debt and lease obligation56,54963,17037,35433,22232,89527,338
Long-term debt, excluding current maturities56,54963,17037,35433,22232,89526,950
Liabilities, other than long-term debt6,3149,3608,4199,0598,9919,643
Deferred income tax liabilities1,6162,354    
Liability for uncertainty in income taxes2,3494,6805,7576,5946,9688,037
Other liabilities2,3492,3262,6622,4652,0231,606
Operating lease, liability      388
Total noncurrent liabilities:62,86372,53045,77342,28141,88636,981
Total liabilities:85,96290,92261,46054,46553,53949,816
Equity
Equity, attributable to parent, including:5,8776,2323,6616,7009,4099,673
Accumulated other comprehensive loss(66)(289)(231)(796)(985)(528)
Accumulated deficit(27,590)(26,549)(28,622)(24,600)(21,408)(21,330)
Other undisclosed equity, attributable to parent33,53333,07032,51432,09631,80231,531
Total equity:5,8776,2323,6616,7009,4099,673
Other undisclosed liabilities and equity      218
TOTAL LIABILITIES AND EQUITY:91,83997,15465,12161,16562,94859,707

Income Statement (P&L) ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues33,42428,19026,32325,97925,42423,362
Cost of revenue
(Cost of Product and Service Sold)
(12,858)(8,451)(6,406)(6,454)(6,159)(4,356)
Gross profit:20,56619,73919,91719,52519,26519,006
Operating expenses(13,308)(11,842)(10,351)(11,886)(10,126)(9,332)
Operating income:7,2587,8979,5667,6399,1399,674
Nonoperating income (expense)5062,833(814)259256753
Investment income, nonoperating5101,200    
Interest and debt expense(3,155)(2,875)(1,406)(1,197)(1,262)(1,289)
Income from continuing operations before equity method investments, income taxes:4,6097,8557,3466,7018,1339,138
Income (loss) from equity method investments 10(11)    
Other undisclosed income (loss) from continuing operations before income taxes (10)11    
Income from continuing operations before income taxes:4,6097,8557,3466,7018,1339,138
Income tax expense(519)(1,138)(794)(808)(869)(1,296)
Income from continuing operations:4,0906,7176,5525,8937,2647,842
Income before gain (loss) on sale of properties:5,8937,2647,842
Net income available to common stockholders, diluted:4,0906,7176,5525,8937,2647,842

Comprehensive Income ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income:4,0906,7176,5525,8937,2647,842
Other comprehensive income (loss)  (58)565189(457)241
Comprehensive income:4,0906,6597,1176,0826,8078,083
Other undisclosed comprehensive income (loss), net of tax, attributable to parent223     
Comprehensive income, net of tax, attributable to parent:4,3136,6597,1176,0826,8078,083

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: